Big Pharma’s China gamble
US House Speaker Mike Johnson sent home Congress members early to avoid a vote on releasing files on Jeffery Epstein, Nigeria’s recalculated GDP reflects a 30 per cent growth of its economy, and US President Donald Trump’s tariffs have hit General Motors' profits. Plus, global pharma companies have spent a record amount on Chinese biotech this year and Coca-Cola is putting cane sugar back in Coke.
Mentioned in this podcast:
Mike Johnson shuts US House early to avoid Epstein vote
Nigeria’s economy 30% bigger after GDP recalculation
Big Pharma is increasingly reliant on Chinese biotech advances
GM profits hit by Trump’s tariffs while EV sales more than double
Coca-Cola to launch cane sugar-based Coke in US this autumn
Today’s FT News Briefing was produced by Sonja Hutson, Katya Kumkova, and Marc Filippino. Additional help from Kelly Garry and Michael Lello. Our acting co-head of audio is Topher Forhecz. Our intern is Michaela Seah. The show’s theme song is by Metaphor Music.
Read a transcript of this episode on FT.com
Hosted on Acast. See acast.com/privacy for more information.
- Datum:
- Duur:
Gerelateerde podcastafleveringen
/https%3A//assets.pippa.io/shows/621e1a5bf5df83377cc948b8/1706278122517-493986eb673bb33dd830c424a3f966d7.jpeg)
Meer afleveringen van FT News Briefing
-
Is Palantir’s stock too good to be true?
-
Australia wants its port back
US President Donald Trump wants to raise tariffs on India and the CEO of Deutsche Bank approved a controversial trade he was later tasked with probing. Plus, Australia wants a port they sold to China back, and Tesla’s board gave chief... -
Wall Street digests bitter economic data
The FT’s US financial commentator joins to discuss how investors are responding to unsettling new economic data, and Germany’s biggest sports retailer is considering relocating some manufacturing to China. Plus, US President Donald...